Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mimedx (MDXG) Other Operating Expenses (2017 - 2019)

Mimedx's Other Operating Expenses history spans 3 years, with the latest figure at $2.3 million for Q4 2019.

  • On a quarterly basis, Other Operating Expenses rose 841.35% to $2.3 million in Q4 2019 year-over-year; TTM through Sep 2020 was $2.3 million, a 190.11% increase, with the full-year FY2020 number at -$8.2 million, changed N/A from a year prior.
  • Other Operating Expenses hit $2.3 million in Q4 2019 for Mimedx, up from -$2.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for MDXG hit a ceiling of $2.3 million in Q4 2019 and a floor of -$2.3 million in Q3 2019.
  • Historically, Other Operating Expenses has averaged -$240600.0 across 3 years, with a median of -$312000.0 in 2018.
  • The widest YoY moves for Other Operating Expenses: up 841.35% in 2019, down 2377.78% in 2019.
  • Tracing MDXG's Other Operating Expenses over 3 years: stood at -$1.0 million in 2017, then soared by 70.23% to -$312000.0 in 2018, then soared by 841.35% to $2.3 million in 2019.
  • Business Quant data shows Other Operating Expenses for MDXG at $2.3 million in Q4 2019, -$2.3 million in Q3 2019, and -$312000.0 in Q4 2018.